Free Trial

Ross Muken Analyst Performance

Analyst at Evercore ISI

Ross Muken is a stock analyst at Evercore ISI, covering 10 publicly traded companies across a range of sectors. Over the past year, Ross Muken has issued 5 stock ratings, including buy and hold recommendations. While full access to Ross Muken's proprietary MarketBeat Analyst Rating is reserved for MarketBeat All Access subscribers, the rating is updated daily to reflect the most recent analyst activity. This profile highlights Ross Muken's coverage history, rating activity, and performance tendencies — helping individual investors make more informed trading decisions.

Analyst Ratings, Coverage, and Performance Statistics

Average Return
00.00% 12-Month ROI
Success Rate
00.00% Profitable Ratings
Total Ratings
19 Last 10 Years
Buy Recommendations
57.89% 11 Buy Ratings
Companies Covered
10 Unique Companies

Ratings Distribution

RatingPercentageCount
Strong Buy0.0%0 ratings
Buy57.9%11 ratings
Hold31.6%6 ratings
Sell10.5%2 ratings

Out of 19 total stock ratings issued by Ross Muken at Evercore ISI, the majority (57.9%) have been Buy recommendations, followed by 31.6% Hold and 10.5% Sell.

Exchange Coverage

ExchangePercentageCount
NYSE
60.0% of companies on NYSE
6 companies
NASDAQ
40.0% of companies on NASDAQ
4 companies

Ross Muken, an analyst at Evercore ISI, currently covers 10 companies listed on NYSE and NASDAQ, with the majority traded on NYSE.

Coverage Focus

Sector IconSectorPercentage
Medical
8 companies
80.0%
Retail/Wholesale
1 company
10.0%
Computer and Technology
1 company
10.0%

Ross Muken of Evercore ISI specializes in stock coverage within the Medical sector, with additional focus on Retail/Wholesale and Computer and Technology companies.

Coverage Industries

IndustryPercentage
MEDICAL SERVICES
4 companies
40.0%
DRUG STORES & PROPRIETARY STORES
2 companies
20.0%
MED/DENTAL - SUPP
1 company
10.0%
MED PRODUCTS
1 company
10.0%
MED INSTRUMENTS
1 company
10.0%
INSTRU - SCIENTFC
1 company
10.0%

Ross Muken's Ratings History at Evercore ISI

Recommendation ROI is the percentage between the price on the Report Date to the price 12 months after the report date.
Available with a MarketBeat All Access Subscription
12-Month ROIUpgrade to All Access to use the All ROI Filter
CompanyReport DateActionReport Date Price12-Month
Price Target
Rating12-Month
Price & ROI
Details
Charles River Laboratories International, Inc. stock logo
CRL
Charles River Laboratories International
8/8/2025Boost Price Target$149.84$190.00Outperform
Henry Schein, Inc. stock logo
HSIC
Henry Schein
8/6/2025Lower Price Target$64.99$70.00In-Line
Icon Plc stock logo
ICLR
Icon
7/25/2025Boost Price Target$186.96$240.00Outperform
Icon Plc stock logo
ICLR
Icon
7/9/2025Boost Price Target$151.58$170.00Outperform
Henry Schein, Inc. stock logo
HSIC
Henry Schein
7/9/2025Boost Price Target$73.95$78.00In-Line